Home › Overweight › Louisiana › New Orleans
Overweight clinical trials in New Orleans, LA
5 studies for Overweight are looking for participants at sites in and around New Orleans (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RecruitingPhase 2
- BRCR Global Louisiana, Gretna · 3 mi away
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Tandem Clinical Research - Marrero, Marrero · 4 mi away
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
RecruitingPhase 3
- DelRicht Clinical Research, LLC, New Orleans
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Ascension DePaul Health, New Orleans
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Tandem Clinical Research - Marrero, Marrero · 4 mi away
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL28 studies
- Orlando, FL27 studies
- Las Vegas, NV23 studies
- Miami, FL23 studies
- Atlanta, GA20 studies
- Dallas, TX20 studies
- New York City, NY19 studies
- Jacksonville, FL19 studies
- Washington, DC19 studies
- Austin, TX18 studies
Other studies in New Orleans
- Breast Cancer12 studies
- Cancer (all types)12 studies
- Ovarian Cancer12 studies
- Non-Small Cell Lung Cancer10 studies
- Prostate Cancer10 studies
- Lung Cancer9 studies
- Endometrial Cancer9 studies
- Metastatic Cancer9 studies
- Cardiovascular Disease9 studies
- Obesity8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.